Filing Details
- Accession Number:
- 0001242616-12-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-04 07:26:49
- Reporting Period:
- 2012-11-30
- Filing Date:
- 2012-12-04
- Accepted Time:
- 2012-12-04 07:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1242616 | E Frank Thomas | 100 Hayden Avenue Lexington MA 02421 | Evp, Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-30 | 10,000 | $0.00 | 17,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-30 | 5,000 | $15.08 | 12,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2012-11-30 | 10,000 | $0.00 | 10,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | No | 4 | M | Direct |
Footnotes
- The shares were acquired by the reporting person as a result of the partial vesting of the restricted stock unit grant described below.
- Not applicable.
- The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The amount reported in this Form 4 includes all shares of common stock beneficially owned by the reporting person, including shares acquired upon the vesting of restricted stock units, which will be included as required in subsequent Forms 4.
- Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer")
- Grant of restricted stock unit pursuant to Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in three installments. The first installment of 10,000 restricted stock units vested on November 30, 2012. The remaining installments of 5,000 restricted stock units each will vest on November 30, 2013 and November 30, 2014, respectively.